Related references
Note: Only part of the references are listed.The mechanism of action of nitric oxide-donating aspirin
Khosrow Kashfi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Chemical insights in the concept of hybrid drugs: The antitumor effect of nitric oxide-donating aspirin involves a quinone methide but not nitric oxide nor aspirin
Niels Hulsman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Cyclo-oxygenase (COX) inhibiting nitric oxide donating (CINODs) drugs: A review of their current status
Fiorucci Stefano et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2007)
Calpain mediates the dioxin-induced activation and down-regulation of the aryl hydrocarbon receptor
Yolanda R. Dale et al.
MOLECULAR PHARMACOLOGY (2006)
High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening
P. J. O'Brien et al.
ARCHIVES OF TOXICOLOGY (2006)
Molecular characterization of cytotoxic and resistance mechanisms induced by NCX 4040, a novel NO-NSAID, in pancreatic cancer cell lines
Marco Rosetti et al.
APOPTOSIS (2006)
Polycyclic aromatic hydrocarbon (PAH) o-quinones produced by the Aldo-Keto-Reductases (AKRs) generate abasic sites, oxidized pyrimidines, and 8-oxo-dGuo via reactive oxygen species
Jong-Heum Park et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2006)
NO-donating aspirin induces phase II enzymes in vitro and in vivo
JJ Gao et al.
CARCINOGENESIS (2006)
Aryl hydrocarbon receptor-mediated transcription:: Ligand-dependent recruitment of estrogen receptor α to 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive promoters
J Matthews et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Cytotoxic effects of 110 reference compounds on HepG2 cells and for 60 compounds on HeLa, ECC-1 and CHO cells.: II -: Mechanistic assays on NAD(P)H, ATP and DNA contents
WGEJ Schoonen et al.
TOXICOLOGY IN VITRO (2005)
Cytotoxic effects of 100 reference compounds on Hep G2 and HeLa cells and of 60 compounds on ECC-1 and CHO cells.: I -: Mechanistic assays on ROS, glutathione depletion and calcein uptake
WGEJ Schoonen et al.
TOXICOLOGY IN VITRO (2005)
5,7-Dimethoxyflavone downregulates CYP1A1 expression and benzo[a]pyrene-induced DNA binding in Hep G2 cells
X Wen et al.
CARCINOGENESIS (2005)
Positional isomerism markedly affects the growth inhibition of colon cancer cells by nitric oxide-donating aspirin in vitro and in vivo
K Kashfi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Risk of cardiovascular events and rofecoxib: cumulative meta-analysis
P Juni et al.
LANCET (2004)
Nitric-oxide-donating NSAIDs as agents for cancer prevention
B Rigas et al.
TRENDS IN MOLECULAR MEDICINE (2004)
NO-donating nonsteroidal antiinflammatory drugs (NSAIDs) inhibit colon cancer cell growth more potently than traditional NSAIDs: a general pharmacological property?
RK Yeh et al.
BIOCHEMICAL PHARMACOLOGY (2004)
The drug salicylamide is an antagonist of the aryl hydrocarbon receptor that inhibits signal transduction induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin
CJ MacDonald et al.
CANCER RESEARCH (2004)
Identification and characterization of novel stable deoxyguanosine and deoxyadenosine adducts of benzo[α]pyrene-7,8-quinone from reactions at physiological pH
N Balu et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2004)
Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study
M Mamdani et al.
LANCET (2004)
Nitric oxide-donating nonsteroidal anti-inflammatory drugs inhibit the growth of various cultured human cancer cells: Evidence of a tissue type-independent effect
K Kashfi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Potential cardioprotective actions of no-releasing aspirin
JL Wallace et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Nonsteroidal anti-inflammatory drugs as anticancer agents: Mechanistic, pharmacologic, and clinical issues
MJ Thun et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
Glutathione conjugation and DNA adduct formation of dibenzo[a,l]pyrene and benzo[a]pyrene diol epoxides in V79 cells stably expressing different human glutathione transferases
K Sundberg et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2002)
Risk of cardiovascular events associated with selective COX-2 inhibitors
D Mukherjee et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Nitric oxide in mucosal defense: A little goes a long way
JL Wallace et al.
GASTROENTEROLOGY (2000)
Role of quinones in toxicology
JL Bolton et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2000)
Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor
Y Shimizu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Chemoprotection against cancer by induction of Phase 2 enzymes
P Talalay
BIOFACTORS (2000)
Share Paper
